Cart
sales@molnova.com
XL177A
CAS No. 2417089-74-6
XL177A ( —— )
Catalog No. M24114 CAS No. 2417089-74-6
XL177A is a selective irreversible USP7 inhibitor(IC50 : 0.34?nM). XL177A elicits cancer cell killing through a p53-dependent mechanism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | In Stock |
|
| 10MG | 282 | In Stock |
|
| 25MG | 480 | In Stock |
|
| 50MG | 691 | In Stock |
|
| 100MG | 972 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXL177A
-
NoteResearch use only, not for human use.
-
Brief DescriptionXL177A is a selective irreversible USP7 inhibitor(IC50 : 0.34?nM). XL177A elicits cancer cell killing through a p53-dependent mechanism.
-
DescriptionXL177A is a selective irreversible USP7 inhibitor(IC50 : 0.34?nM). XL177A elicits cancer cell killing through a p53-dependent mechanism.
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorUSP7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2417089-74-6
-
Formula Weight861.5
-
Molecular FormulaC48H57ClN8O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC(N=CN2CC3(O)CCN(C([C@H](CC4=CC=CC=C4)CCCNC(C5=CC(N=C(CCCC6)C6=C7Cl)=C7C=C5)=O)=O)CC3)=C(C=C1)C2=O)CCN8CCN(C)CC8
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nathan J Schauer, et al. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism. Sci Rep.2020 Mar 24;10(1):5324.
molnova catalog
related products
-
PR-619
PR-619 is a non-selective, reversible inhibitor of the deubiquitinylating enzymes (DUBs) with EC50 of 1-20 μM in a cell-free assay.
-
IU1-47
IU1-47 is a potent, selective small-molecule inhibitor of USP14 with IC50 of 0.6 uM.
-
HBX 41108
HBx 41108 is a non-competitive, reversible inhibitor of USP7 with an IC50 of 424nM. HBx 41108 inhibited deubiquitination of p53 mediated by USP7 in a dose-dependent manner with an IC50 of 0.8μM.
